150 Mg Trastuzumab For Injection

Name: 150 Mg Trastuzumab For Injection
Brand: NEETCO BIOPHARMA
Price: 4000 INR
Availability: InStock

Price 4000 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

150 Mg Trastuzumab For Injection Specification

Dosage Form
Lyophilized Powder for Injection

Salt Composition
Trastuzumab 150 mg

Indication
HER2-positive breast cancer and HER2-overexpressing metastatic gastric cancer

Enzyme Types
Monoclonal Antibody (not an enzyme)

Feature
Humanized monoclonal antibody targeting HER2 protein

Ingredients
Trastuzumab, L-histidine, L-histidine hydrochloride, Trehalose, Polysorbate 20

Application
Intravenous infusion, under physician supervision

Ph Level
Approximately 5.5 to 6.0

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Not applicable (monoclonal antibody)

Storage Instructions
Store at 2C to 8C; do not freeze

Shelf Life
24 months

About 150 Mg Trastuzumab For Injection

Advance Purchase of our best-seller 150 mg Trastuzumab For Injection brings a fresh and valuable solution for patients diagnosed with HER2-positive breast cancer or HER2-overexpressing metastatic gastric cancer. This gorgeous, noble formulation is a humanized monoclonal antibody, offering targeted antineoplastic action. Delivered as a white to off-white lyophilized powder, it's odorless and packed in a secure glass vial with a rubber stopper. Each single vial is intended for intravenous administration, reconstituted with 7.2 mL sterile water, then further diluted with 0.9% sodium chloride. A prescription-only medicine, it is contraindicated in cases of hypersensitivity to trastuzumab or its excipients. Store in cold conditions for enduring freshness and efficacy.

Versatile Usage & Superior Advantages

150 Mg Trastuzumab For Injection is specifically used for intravenous infusion in HER2-positive breast cancer and metastatic gastric cancer. Its site of application is strictly hospital or clinical under physician supervision, ensuring precision and safety. The product's primary competitive advantages include potent targeted therapy, a reliable supply chain, and high purity, preserving its valuable therapeutic properties for optimal patient benefit.

Efficient Delivery, Exports & Sample Availability

We ensure prompt delivery times and cater to major export markets like India and other regions. Whether your interest is a quotation or direct supply, we offer competitive sale prices and seamless exchange processes. Sample vials are available on request, supporting informed clinical decisions. Our streamlined logistics guarantee dependable access for distributors, exporters, suppliers, and traders seeking superior monoclonal antibody therapies.

FAQ's of 150 Mg Trastuzumab For Injection:

Q: How should 150 Mg Trastuzumab For Injection be administered?

A: The injection must be given intravenously, following reconstitution with sterile water and further dilution with 0.9% sodium chloride under the supervision of a qualified healthcare professional.

Q: What conditions does this product target?

A: 150 Mg Trastuzumab For Injection is indicated for the treatment of HER2-positive breast cancer and HER2-overexpressing metastatic gastric cancer.

Q: Where can the product be stored to guarantee efficacy?

A: The glass vial should be stored at 2C to 8C; freezing must be avoided to maintain the product's integrity and therapeutic value.

Q: What is the process for reconstituting this medication?

A: Reconstitution requires adding 7.2 mL of sterile water for injection directly into the vial, followed by further dilution with 0.9% sodium chloride before intravenous infusion.

Q: How does Trastuzumab as a monoclonal antibody benefit patients?

A: Trastuzumab targets the HER2 protein found in cancer cells, resulting in precise antineoplastic effects and improved treatment outcomes for eligible patients.